The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...
My name is Todd Tushla, I'm the Vice President of Investor Relations at Neurocrine Biosciences. And on behalf of our entire company, welcome to our 2025 R&D Day, whether you're here in person, on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback